Crewe Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.4K Buy
260
+56
+27% +$15.5K ﹤0.01% 416
2026
Q1
$60.3K Buy
204
+24
+13% +$7.13K 0.01% 361
2025
Q4
$49.2K Buy
180
+17
+10% +$4.62K ﹤0.01% 368
2025
Q3
$44K Buy
163
+13
+9% +$3.54K ﹤0.01% 397
2025
Q2
$41.3K Hold
150
0.01% 307
2025
Q1
$39.8K Hold
150
0.01% 289
2024
Q4
$34.8K Sell
150
-387
-72% -$89K ﹤0.01% 309
2024
Q3
$118K Buy
537
+3
+0.6% +$621 0.01% 209
2024
Q2
$105K Sell
534
-25
-4% -$5.17K 0.01% 262
2024
Q1
$120K Buy
+559
New +$117K 0.01% 245
2023
Q3
Sell
-144
Closed -$26.7K 650
2023
Q2
$26.7K Sell
144
-622
-81% -$115K ﹤0.01% 325
2023
Q1
$147K Sell
766
-28
-4% -$5.06K 0.02% 188
2022
Q4
$134K Buy
794
+204
+35% +$35.5K 0.02% 193
2022
Q3
$105K Buy
590
+74
+14% +$14.6K 0.02% 219
2022
Q2
$106K Buy
516
+341
+195% +$72.3K 0.02% 204
2022
Q1
$42K Buy
+175
New +$41.1K 0.01% 235
2019
Q3
Sell
-19
Closed -$4K 231
2019
Q2
$4K Hold
19
﹤0.01% 244
2019
Q1
$3K Buy
+19
New +$3.36K ﹤0.01% 208

Other funds holding CME

Crewe Advisors's CME Position: Q2 2026 in Review

Crewe Advisors increased its CME Group (CME) stake by 27% in Q2 2026, buying an estimated $15.5K and bringing the position to 260 shares worth $57.4K. The position accounts for ﹤0.01% of the portfolio, ranked #416.

Crewe Advisors first reported a position in CME in Q1 2019 and has held it in 18 quarters since. The position peaked at $147K in Q1 2023. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Crewe Advisors held 260 shares of CME Group worth $57.4K as of Q2 2026.
  • Crewe Advisors bought 56 CME Group shares in Q2 2026, an estimated $15.5K.
  • CME Group made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #416 holding.
  • Crewe Advisors first reported a position in CME Group in Q1 2019 and has held it in 18 quarters since.
  • Crewe Advisors's CME Group position peaked at $147K in Q1 2023.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.